Comparative pathogenesis of three human and zoonotic sars-cov strains in cynomolgus macaques

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Rockx, Barry ^a,d   Feldmann, Friederike ^a   Brining, Douglas ^a   Gardner, Don ^a   LaCasse, Rachel ^a   Kercher, Lisa ^a   Long, Dan ^a   Rosenke, Rebecca ^a   Virtaneva, Kimmo ^a   Sturdevant, Daniel E ^a   Porcella, Stephen F ^a   Mattoon, John ^b   Parnell, Michael ^a   Baric, Ralph S ^c   Feldmann, Heinz ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MESSENGER RNA; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROVOCATION TEST; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; THORAX RADIOGRAPHY; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; ZOONOSIS; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE TRANSMISSION; HUMAN; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MACACA; SARS CORONAVIRUS;

ANIMALS; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS REPLICATION; ZOONOSES;

EID: 79955457608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018558     Document Type: Article

References (44)

1. Chan-Yeung M, Xu RH, (2003) SARS: epidemiology. Respirology 8 (Suppl): S9-14.
2. Chinese SMEC, (2004) Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303: 1666-1669.
3. Li W, Shi Z, Yu M, Ren W, Smith C, et al. (2005) Bats are natural reservoirs of SARS-like coronaviruses. Science 310: 676-679.
4. Liu M, Liang WN, Chen Q, Xie XQ, Wu J, et al. (2006) Risk factors for SARS-related deaths in 2003, Beijing. Biomed Environ Sci 19: 336-339.
5. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, et al. (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450-454.
6. Holmes EC, Rambaut A, (2004) Viral evolution and the emergence of SARS coronavirus. Philos Trans R Soc Lond B Biol Sci 359: 1059-1065.
7. Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, et al. (2005) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. Embo J 24: 1634-1643.
8. Sheahan T, Rockx B, Donaldson E, Sims A, Pickles R, et al. (2008) Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J Virol 82: 2274-2285.
9. Enjuanes L, Dediego ML, Alvarez E, Deming D, Sheahan T, et al. (2007) Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease. Virus Res.
10. Rockx B, Baric RS, (2007) Grand Challenges in Human Coronavirus Vaccine Development Coronaviruses Molecular and Cellular Biology pp. 257-286.
11. Osterhaus AD, Fouchier RA, Kuiken T, (2004) The aetiology of SARS: Koch's postulates fulfilled. Philos Trans R Soc Lond B Biol Sci 359: 1081-1082.
12. ter Meulen J, Bakker AB, van den Brink EN, Weverling GJ, Martina BE, et al. (2004) Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363: 2139-2141.
13. Qin C, Wang J, Wei Q, She M, Marasco WA, et al. (2005) An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J Pathol 206: 251-259.
14. Roberts A, Vogel L, Guarner J, Hayes N, Murphy B, et al. (2005) Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol 79: 503-511.
15. Lawler JV, Endy TP, Hensley LE, Garrison A, Fritz EA, et al. (2006) Cynomolgus Macaque as an Animal Model for Severe Acute Respiratory Syndrome. PLoS Med 3: e149.
16. Roberts A, Deming D, Paddock CD, Cheng A, Yount B, et al. (2007) A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 3: e5.
17. Roberts A, Lamirande EW, Vogel L, Jackson JP, Paddock CD, et al. (2007) Animal models and vaccines for SARS-CoV infection. Virus Res.
18. Deming D, Sheahan T, Heise M, Yount B, Davis N, et al. (2006) Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants. PLoS Med 3: e525.
19. Rockx B, Sheahan T, Donaldson E, Harkema J, Sims A, et al. (2007) Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice. J Virol 81: 7410-7423.
20. Rockx B, Baas T, Zornetzer GA, Haagmans B, Sheahan T, et al. (2009) Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol 83: 7062-7074.
21. McAuliffe J, Vogel L, Roberts A, Fahle G, Fischer S, et al. (2004) Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology 330: 8-15.
22. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, et al. (2003) Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263-270.
23. Rowe T, Gao G, Hogan RJ, Crystal RG, Voss TG, et al. (2004) Macaque model for severe acute respiratory syndrome. J Virol 78: 11401-11404.
24. Smits SL, de Lang A, van den Brand JM, Leijten LM, van IWF, et al. (2010) Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog 6: e1000756.
25. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, et al. (2010) Pandemic Swine-Origin H1N1 Influenza A Isolates Show Heterogeneous Virulence in Macaques. J Virol.
26. Zeng FY, Chan CW, Chan MN, Chen JD, Chow KY, et al. (2003) The complete genome sequence of severe acute respiratory syndrome coronavirus strain HKU-39849 (HK-39). Exp Biol Med (Maywood) 228: 866-873.
27. Sheahan T, Rockx B, Donaldson E, Corti D, Baric R, (2008) Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus. J Virol 82: 8721-8732.
28. de Lang A, Osterhaus AD, Haagmans BL, (2006) Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. Virology 353: 474-481.
29. Glowacka I, Bertram S, Herzog P, Pfefferle S, Steffen I, et al. (2010) Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol 84: 1198-1205.
30. Kuba K, Imai Y, Rao S, Gao H, Guo F, et al. (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11: 875-879.
31. Xue X, Gao Z, Xu Y, Ding X, Yuan L, et al. (2003) Clinical analysis of 45 patients with severe acute respiratory syndrome. Chin Med J (Engl) 116: 819-822.
32. Isakbaeva ET, Khetsuriani N, Beard RS, Peck A, Erdman D, et al. (2004) SARS-associated coronavirus transmission, United States. Emerg Infect Dis 10: 225-231.
33. Wang B, Zhang A, Sun JL, Liu H, Hu J, et al. (2005) Study of SARS transmission via liquid droplets in air. J Biomech Eng 127: 32-38.
34. Nicholls J, Dong XP, Jiang G, Peiris M, (2003) SARS: clinical virology and pathogenesis. Respirology 8 (Suppl): S6-8.
35. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, et al. (2007) Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 81: 8692-8706.
36. de Lang A, Baas T, Teal T, Leijten LM, Rain B, et al. (2007) Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques. PLoS Pathog 3: e112.
37. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319-323.
38. Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, et al. (2005) Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med 171: 850-857.
39. Tang NL, Chan PK, Wong CK, To KF, Wu AK, et al. (2005) Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem 51: 2333-2340.
40. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, et al. (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136: 95-103.
41. Yu SY, Hu YW, Liu XY, Xiong W, Zhou ZT, et al. (2005) Gene expression profiles in peripheral blood mononuclear cells of SARS patients. World J Gastroenterol 11: 5037-5043.
42. Chien JY, Hsueh PR, Cheng WC, Yu CJ, Yang PC, (2006) Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome. Respirology 11: 715-722.
43. Rockx B, Donaldson E, Frieman M, Sheahan T, Corti D, et al. (2010) Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. J Infect Dis 201: 946-955.
44. Virtaneva K, Porcella SF, Graham MR, Ireland RM, Johnson CA, et al. (2005) Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci U S A 102: 9014-9019.